Literature DB >> 11444411

Chronic renal failure secondary to oxalate nephropathy: a preventable complication after jejunoileal bypass.

I Hassan1, L A Juncos, D S Milliner, J M Sarmiento, M G Sarr.   

Abstract

Enteric hyperoxaluria is a commonly seen adverse event after the jejunoileal bypass procedure. The increased concentration of urinary oxalate predisposes bypass patients to various renal complications such as nephrolithiasis and oxalate nephropathy. If not diagnosed and appropriately treated, these complications can lead to irreversible renal damage. We describe 3 patients in whom severe renal complications developed with irreversible compromise of renal function after a jejunoileal bypass. Patients who undergo a jejunoileal bypass require lifelong follow-up with close monitoring of their renal function. Marked decline in renal function mandates prompt investigation and aggressive intervention, including reversal of the jejunoileal bypass if necessary. Chronic renal failure secondary to oxalate nephropathy is preventable and treatable but may require conversion of a jejunoileal bypass to a more current form of bypass.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11444411     DOI: 10.4065/76.7.758

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  13 in total

1.  Nephrolithiasis and nephrocalcinosis in rats with small bowel resection.

Authors:  R Corey O'Connor; Elaine M Worcester; Andrew P Evan; Shane Meehan; Dimitri Kuznetsov; Brett Laven; Andre' J Sommer; Sharon B Bledsoe; Joan H Parks; Fredric L Coe; Marc Grynpas; Glenn S Gerber
Journal:  Urol Res       Date:  2005-05

Review 2.  Nephropathy in dietary hyperoxaluria: A potentially preventable acute or chronic kidney disease.

Authors:  Robert H Glew; Yijuan Sun; Bruce L Horowitz; Konstantin N Konstantinov; Marc Barry; Joanna R Fair; Larry Massie; Antonios H Tzamaloukas
Journal:  World J Nephrol       Date:  2014-11-06

Review 3.  Enteric hyperoxaluria: an important cause of end-stage kidney disease.

Authors:  Lama Nazzal; Sonika Puri; David S Goldfarb
Journal:  Nephrol Dial Transplant       Date:  2015-02-20       Impact factor: 5.992

4.  Plasma oxalate level in pediatric calcium stone formers with or without secondary hyperoxaluria.

Authors:  Przemysław Sikora; Bodo Beck; Małgorzata Zajaczkowska; Bernd Hoppe
Journal:  Urol Res       Date:  2009-01-30

5.  Continuous infusion of oxalate by minipumps induces calcium oxalate nephrocalcinosis.

Authors:  Susan Ruth Marengo; Daniel H-C Chen; Andrew P Evan; Andre J Sommer; Nicholas T Stowe; Donald G Ferguson; Martin I Resnick; Gregory T MacLennan
Journal:  Urol Res       Date:  2006-02-15

Review 6.  Benchmarking best practices in weight loss surgery.

Authors:  Robert B Lim; George L Blackburn; Daniel B Jones
Journal:  Curr Probl Surg       Date:  2010-02       Impact factor: 1.909

7.  Shedding light on the chemical diversity of ectopic calcifications in kidney tissues: diagnostic and research aspects.

Authors:  Arnaud Dessombz; Dominique Bazin; Paul Dumas; Christophe Sandt; Josep Sule-Suso; Michel Daudon
Journal:  PLoS One       Date:  2011-11-18       Impact factor: 3.240

8.  Transplantation for renal failure secondary to enteric hyperoxaluria: a case report.

Authors:  Stephen I Rifkin
Journal:  J Med Case Rep       Date:  2007-06-25

9.  Vitamin C-induced hyperoxaluria causing reversible tubulointerstitial nephritis and chronic renal failure: a case report.

Authors:  Shradha Rathi; William Kern; Kai Lau
Journal:  J Med Case Rep       Date:  2007-11-27

Review 10.  Bariatric surgery and the kidney-much benefit, but also potential harm.

Authors:  Eberhard Ritz
Journal:  Clin Kidney J       Date:  2012-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.